described as noncompetitive AMPA-type glutamate receptor antagonists, more potent than GYKI 52466. New synthesized compounds proved to be able to protect against seizures induced by means of auditory stimulation in DBA/2 mice and compound 8f the most active of the series showed anticonvulsant properties comparable to GYKI 52466.
从相应的双环1-芳基-3,5-二氢-7开始,合成了一系列新的3-乙氧基羰基-11H- [1,2,4]三唑并[4,5-c] [2,3]苯并二氮杂,,以前被描述为非竞争性
AMPA型谷
氨酸受体拮抗剂的8-二甲氧基-4H-2,3-苯并二氮杂-4-酮(C
FM)比GYKI 52466更有效。事实证明,新合成的化合物能够防止由GYKI引起的癫痫发作在该系列中最活跃的
DBA / 2小鼠和化合物8f的听觉刺激中,其抗惊厥特性与GYKI 52466相当。